nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—Isopropamide—Propantheline—pancreatitis	0.965	1	CrCrCtD
Levomethadyl Acetate—CYP19A1—Biological oxidations—ALDH2—pancreatitis	0.000173	0.00498	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	0.000165	0.00474	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CASR—pancreatitis	0.00016	0.0046	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—pancreatitis	0.000156	0.00448	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—ADH1B—pancreatitis	0.000154	0.00443	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—MTNR1B—pancreatitis	0.000153	0.00439	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—ALDH2—pancreatitis	0.00015	0.00432	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CNR2—pancreatitis	0.000149	0.00428	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Tryptophan metabolism—ALDH2—pancreatitis	0.000145	0.00417	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—pancreatitis	0.000143	0.0041	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	0.000142	0.00408	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	0.000138	0.00397	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—SST—pancreatitis	0.000137	0.00394	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000136	0.00391	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	0.000136	0.00391	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.000135	0.00388	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—CXCL8—pancreatitis	0.000134	0.00384	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—BDKRB2—pancreatitis	0.000129	0.00371	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—IL1B—pancreatitis	0.000128	0.00369	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—CASP3—pancreatitis	0.000128	0.00368	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—PPY—pancreatitis	0.000126	0.00361	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	0.000125	0.00359	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	0.000122	0.00349	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	0.000122	0.00349	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	0.000118	0.0034	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	0.000118	0.0034	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—KNG1—pancreatitis	0.000118	0.00337	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—MDM2—pancreatitis	0.000117	0.00337	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.000117	0.00335	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—SST—pancreatitis	0.000116	0.00333	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.000113	0.00324	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—BDKRB2—pancreatitis	0.000109	0.00313	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—ALDH2—pancreatitis	0.000109	0.00312	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—MDM2—pancreatitis	0.000107	0.00308	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CNR1—pancreatitis	0.000107	0.00307	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—FDX1—pancreatitis	0.000104	0.00297	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.000101	0.0029	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	9.93e-05	0.00285	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—KNG1—pancreatitis	9.91e-05	0.00285	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL5—pancreatitis	9.83e-05	0.00282	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—SCT—pancreatitis	9.71e-05	0.00279	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CASR—pancreatitis	9.71e-05	0.00279	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—ADH4—pancreatitis	9.63e-05	0.00276	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	9.52e-05	0.00273	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CX3CL1—pancreatitis	9.52e-05	0.00273	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—IL1B—pancreatitis	9.33e-05	0.00268	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—TNF—pancreatitis	9.31e-05	0.00267	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCK—pancreatitis	9.26e-05	0.00266	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—MTNR1B—pancreatitis	9.26e-05	0.00266	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	9.21e-05	0.00265	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CNR2—pancreatitis	9.02e-05	0.00259	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—TACR1—pancreatitis	9.02e-05	0.00259	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—MDM2—pancreatitis	8.99e-05	0.00258	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCKAR—pancreatitis	8.88e-05	0.00255	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	8.66e-05	0.00249	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatitis	8.56e-05	0.00246	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	8.5e-05	0.00244	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CCL5—pancreatitis	8.29e-05	0.00238	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—MDM2—pancreatitis	8.22e-05	0.00236	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	8.03e-05	0.00231	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	7.88e-05	0.00226	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatitis	7.83e-05	0.00225	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—PTHLH—pancreatitis	7.67e-05	0.0022	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—SMO—pancreatitis	7.67e-05	0.0022	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	7.53e-05	0.00216	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—IL6—pancreatitis	7.52e-05	0.00216	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—A2M—pancreatitis	7.27e-05	0.00209	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—TGFB1—pancreatitis	7.25e-05	0.00208	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—ADH1B—pancreatitis	7.18e-05	0.00206	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PPY—pancreatitis	7.1e-05	0.00204	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—SST—pancreatitis	7.02e-05	0.00202	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CTRB2—pancreatitis	7e-05	0.00201	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—pancreatitis	6.81e-05	0.00196	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	6.78e-05	0.00195	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL2—pancreatitis	6.77e-05	0.00194	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—BDKRB2—pancreatitis	6.6e-05	0.00189	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	6.59e-05	0.00189	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CNR1—pancreatitis	6.48e-05	0.00186	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PPY—pancreatitis	6.44e-05	0.00185	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—HRAS—pancreatitis	6.44e-05	0.00185	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—GCG—pancreatitis	6.25e-05	0.0018	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—pancreatitis	6.1e-05	0.00175	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CTRB2—pancreatitis	6.08e-05	0.00175	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—FDX1—pancreatitis	6.07e-05	0.00174	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—KNG1—pancreatitis	6e-05	0.00172	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—HRAS—pancreatitis	5.89e-05	0.00169	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	5.81e-05	0.00167	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—HRAS—pancreatitis	5.71e-05	0.00164	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ADH4—pancreatitis	5.64e-05	0.00162	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—SCT—pancreatitis	5.48e-05	0.00158	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CASR—pancreatitis	5.48e-05	0.00158	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—IL6—pancreatitis	5.47e-05	0.00157	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL8—pancreatitis	5.35e-05	0.00154	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PRSS1—pancreatitis	5.3e-05	0.00152	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—FDX1—pancreatitis	5.27e-05	0.00151	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CCK—pancreatitis	5.23e-05	0.0015	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—MTNR1B—pancreatitis	5.23e-05	0.0015	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	5.15e-05	0.00148	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—TACR1—pancreatitis	5.1e-05	0.00146	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CNR2—pancreatitis	5.1e-05	0.00146	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—ALDH2—pancreatitis	5.06e-05	0.00145	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PNLIP—pancreatitis	5.03e-05	0.00144	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PRSS3—pancreatitis	5.03e-05	0.00144	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCL5—pancreatitis	5.02e-05	0.00144	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CCKAR—pancreatitis	5.02e-05	0.00144	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—SCT—pancreatitis	4.98e-05	0.00143	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CASR—pancreatitis	4.98e-05	0.00143	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—HRAS—pancreatitis	4.93e-05	0.00142	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ADH4—pancreatitis	4.9e-05	0.00141	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CX3CL1—pancreatitis	4.88e-05	0.0014	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCK—pancreatitis	4.75e-05	0.00136	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—MTNR1B—pancreatitis	4.75e-05	0.00136	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CNR2—pancreatitis	4.63e-05	0.00133	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—TACR1—pancreatitis	4.63e-05	0.00133	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PRSS1—pancreatitis	4.61e-05	0.00132	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCKAR—pancreatitis	4.56e-05	0.00131	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	4.54e-05	0.0013	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL8—pancreatitis	4.51e-05	0.0013	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—HRAS—pancreatitis	4.51e-05	0.0013	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—XDH—pancreatitis	4.51e-05	0.0013	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—HTR2A—pancreatitis	4.42e-05	0.00127	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—pancreatitis	4.4e-05	0.00126	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CTRB2—pancreatitis	4.39e-05	0.00126	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PNLIP—pancreatitis	4.37e-05	0.00125	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PRSS3—pancreatitis	4.37e-05	0.00125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PTHLH—pancreatitis	4.34e-05	0.00125	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PNLIP—pancreatitis	4.24e-05	0.00122	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ADH1B—pancreatitis	4.21e-05	0.00121	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—SST—pancreatitis	3.97e-05	0.00114	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—pancreatitis	3.96e-05	0.00114	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PTHLH—pancreatitis	3.94e-05	0.00113	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—SMO—pancreatitis	3.94e-05	0.00113	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—XDH—pancreatitis	3.92e-05	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—FDX1—pancreatitis	3.81e-05	0.00109	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PPY—pancreatitis	3.81e-05	0.00109	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PPP3CA—pancreatitis	3.76e-05	0.00108	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—BDKRB2—pancreatitis	3.73e-05	0.00107	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CNR1—pancreatitis	3.66e-05	0.00105	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ADH1B—pancreatitis	3.65e-05	0.00105	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—SST—pancreatitis	3.6e-05	0.00103	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	3.59e-05	0.00103	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ADH4—pancreatitis	3.54e-05	0.00102	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—GCG—pancreatitis	3.53e-05	0.00101	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCL2—pancreatitis	3.46e-05	0.000993	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—KNG1—pancreatitis	3.39e-05	0.000974	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—BDKRB2—pancreatitis	3.39e-05	0.000972	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PLA2G1B—pancreatitis	3.35e-05	0.000963	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PRSS1—pancreatitis	3.33e-05	0.000956	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CNR1—pancreatitis	3.32e-05	0.000954	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—A2M—pancreatitis	3.24e-05	0.00093	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GCG—pancreatitis	3.21e-05	0.000922	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PRSS3—pancreatitis	3.16e-05	0.000906	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PNLIP—pancreatitis	3.16e-05	0.000906	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—KNG1—pancreatitis	3.08e-05	0.000885	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ALDH2—pancreatitis	2.96e-05	0.000851	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SCT—pancreatitis	2.94e-05	0.000845	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FGG—pancreatitis	2.94e-05	0.000845	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CASR—pancreatitis	2.94e-05	0.000845	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PLA2G1B—pancreatitis	2.91e-05	0.000837	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	2.89e-05	0.00083	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CX3CL1—pancreatitis	2.89e-05	0.000829	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CCL5—pancreatitis	2.84e-05	0.000814	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—XDH—pancreatitis	2.83e-05	0.000813	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—A2M—pancreatitis	2.81e-05	0.000808	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MTNR1B—pancreatitis	2.81e-05	0.000806	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCK—pancreatitis	2.81e-05	0.000806	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—A2M—pancreatitis	2.74e-05	0.000785	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CNR2—pancreatitis	2.74e-05	0.000785	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TACR1—pancreatitis	2.74e-05	0.000785	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CXCL8—pancreatitis	2.73e-05	0.000785	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCKAR—pancreatitis	2.69e-05	0.000773	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ADH1B—pancreatitis	2.64e-05	0.000758	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	2.6e-05	0.000746	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCL5—pancreatitis	2.58e-05	0.00074	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ALDH2—pancreatitis	2.57e-05	0.000739	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FGA—pancreatitis	2.5e-05	0.000718	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—HTR2A—pancreatitis	2.5e-05	0.000718	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PTHLH—pancreatitis	2.33e-05	0.000668	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SMO—pancreatitis	2.33e-05	0.000668	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FGB—pancreatitis	2.28e-05	0.000654	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	2.27e-05	0.000653	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HTR2A—pancreatitis	2.27e-05	0.000652	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GCG—pancreatitis	2.25e-05	0.000645	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PPP3CA—pancreatitis	2.22e-05	0.000637	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SST—pancreatitis	2.13e-05	0.000611	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—DUSP6—pancreatitis	2.11e-05	0.000606	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PLA2G1B—pancreatitis	2.11e-05	0.000605	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CTRB2—pancreatitis	2.04e-05	0.000586	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—A2M—pancreatitis	2.03e-05	0.000584	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—BDKRB2—pancreatitis	2e-05	0.000574	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CNR1—pancreatitis	1.96e-05	0.000564	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GCG—pancreatitis	1.95e-05	0.00056	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GCG—pancreatitis	1.9e-05	0.000544	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ALDH2—pancreatitis	1.86e-05	0.000534	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KNG1—pancreatitis	1.82e-05	0.000523	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCL2—pancreatitis	1.77e-05	0.00051	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—FDX1—pancreatitis	1.77e-05	0.000508	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—LPL—pancreatitis	1.76e-05	0.000506	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PDGFA—pancreatitis	1.67e-05	0.000481	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ADH4—pancreatitis	1.65e-05	0.000473	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PRSS1—pancreatitis	1.55e-05	0.000444	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CXCL8—pancreatitis	1.54e-05	0.000444	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—LPL—pancreatitis	1.53e-05	0.000439	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCL5—pancreatitis	1.52e-05	0.000437	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LPL—pancreatitis	1.49e-05	0.000427	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PRSS3—pancreatitis	1.47e-05	0.000421	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PNLIP—pancreatitis	1.47e-05	0.000421	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GCG—pancreatitis	1.41e-05	0.000405	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SPP1—pancreatitis	1.41e-05	0.000405	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CXCL8—pancreatitis	1.4e-05	0.000403	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HTR2A—pancreatitis	1.34e-05	0.000385	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—XDH—pancreatitis	1.32e-05	0.000378	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PPARG—pancreatitis	1.29e-05	0.000369	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—INS—pancreatitis	1.26e-05	0.000362	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—LEP—pancreatitis	1.25e-05	0.000358	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ADH1B—pancreatitis	1.23e-05	0.000352	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ALB—pancreatitis	1.16e-05	0.000332	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—NRAS—pancreatitis	1.13e-05	0.000323	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PPARG—pancreatitis	1.12e-05	0.000321	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—LPL—pancreatitis	1.11e-05	0.000318	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—INS—pancreatitis	1.1e-05	0.000315	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—INS—pancreatitis	1.07e-05	0.000306	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCL2—pancreatitis	1.05e-05	0.000301	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS2—pancreatitis	1.01e-05	0.000291	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ALB—pancreatitis	1e-05	0.000288	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PLA2G1B—pancreatitis	9.79e-06	0.000281	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—KRAS—pancreatitis	9.69e-06	0.000278	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—A2M—pancreatitis	9.45e-06	0.000272	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MDM2—pancreatitis	8.86e-06	0.000255	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS2—pancreatitis	8.79e-06	0.000252	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ALDH2—pancreatitis	8.65e-06	0.000248	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CXCL8—pancreatitis	8.29e-06	0.000238	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HRAS—pancreatitis	8.23e-06	0.000236	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PPARG—pancreatitis	8.08e-06	0.000232	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CASP3—pancreatitis	7.93e-06	0.000228	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—INS—pancreatitis	7.92e-06	0.000227	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL6—pancreatitis	7.88e-06	0.000226	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ALB—pancreatitis	7.26e-06	0.000209	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NRAS—pancreatitis	6.65e-06	0.000191	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GCG—pancreatitis	6.55e-06	0.000188	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS2—pancreatitis	6.35e-06	0.000182	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TGFB1—pancreatitis	6.18e-06	0.000177	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KRAS—pancreatitis	5.72e-06	0.000164	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—LPL—pancreatitis	5.14e-06	0.000148	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HRAS—pancreatitis	4.86e-06	0.00014	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL6—pancreatitis	4.66e-06	0.000134	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PPARG—pancreatitis	3.75e-06	0.000108	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—INS—pancreatitis	3.68e-06	0.000106	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ALB—pancreatitis	3.38e-06	9.7e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS2—pancreatitis	2.95e-06	8.48e-05	CbGpPWpGaD
